NCIt definition : A monoclonal antibody directed against human transforming growth factor beta (TGF-beta),
with potential antineoplastic activity. Upon administration, nisevokitug targets and
binds to TGF-beta, thereby preventing the activation of TGF-beta-mediated signaling
pathways. TGF-beta, a pro-inflammatory mediator that is mutated and/or overexpressed
in a number of cancer cell types, is involved in cancer cell proliferation and migration,
and tumor progression.;
UNII : W2OR26S7UE;
CAS number : 2649854-92-0; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2649854-92-0
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;